Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-16

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Granules Pharmaceuticals Inc.'s original application for lisdexamfetamine dimesylate, a generic version of the ADHD medication, with indications in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)